top of page
NLA_SS_Web Banner Mockup (1).jpg

2022 NLA Scientific Sessions Abstracts

Click on the posters to see an enlarged version, or scan the QR Codes with your phone to have a touch-free experience. 

The NLRP3 inhibitor and Nrf2 agonist, RRx-001, ameliorates non-alcoholic fatty liver disease in rats

Presenting Author: Bryan Oronsky
Authors: Pedro Cabrales, Scott Caroen, Tony Reid

Poster 19.jpg

Kiosk 7

Eicosapentaenoic Acid (EPA) Modulates Expression of Inflammatory Proteins in Pulmonary Endothelial Cells following Exposure to Air Pollution Particle Matter

Presenting Author: RP Mason
Authors: Peter Libby, Deepak L. Bhatt, R. Preston Mason


Kiosk 7

Does Cholesterol Screening in Prader-Willi Syndrome Represent an Opportunity to Reduce Cardiovascular Disease Risk?

Presenting Author: Don Wilson
Authors: Emily Topham, Sani Roy, MD, Luke Hamilton, MS, Don Wilson, MD


Kiosk 7

bottom of page